APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biobanking

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Selected research

Market Outlook & Growth Opportunities

Global Biobanking Market Outlook and Growth Opportunities 2026

21 December 2025216 pages

Choose your research edition.

Industry ResearchBiobanking Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Biobanking Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Biobanking Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biobanking Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Biobanking Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.

United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.

Read the full market overview

In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.

This report provides an overview of the global Biobanking market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biobanking and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biobanking revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biobanking market.

Biobanking Segment by Company

Thermo Fisher

Beckman Coulter

Panasonic

SOL Group

Promega

Merck

Greiner Bio One

Chart Industries

Brooks Life Science

Tecan Group

QIAGEN

BD

Lifeline Scientific

Hamilton

So-Low

TTP Labtech Ltd

Biolife Solutions

DNA Genotek

Custom Biogenic Systems

LVL Technologies

BioRep

Biobanking Segment by Type

Equipment

Consumable

Biobanking Segment by Application

Virtual Biobanks

Tissue Biobanks

Population Biobanks

Biobanking Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biobanking status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biobanking key companies, revenue, market share, and recent developments.

3. To split the Biobanking breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biobanking market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biobanking significant trends, drivers, influence factors in global and regions.

6. To analyze Biobanking competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biobanking industry.

Chapter 3: Detailed analysis of Biobanking company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biobanking in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biobanking in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biobanking Industry Trends Table 2. Biobanking Industry Drivers Table 3. Biobanking Industry Opportunities and Challenges Table 4. Biobanking Industry Restraints Table 5. Global Biobanking Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biobanking Revenue Share by Company (2021-2026) Table 7. Global Biobanking Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biobanking Key Company Manufacturing Base & Headquarters Table 9. Global Biobanking Company, Product Type & Application Table 10. Global Biobanking Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biobanking by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Equipment Table 15. Significant Companies of Consumable Table 16. Global Biobanking Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biobanking Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biobanking Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biobanking Sales Value Share by Type (2021-2026) Table 20. Global Biobanking Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Virtual Biobanks Table 22. Significant Companies of Tissue Biobanks Table 23. Significant Companies of Population Biobanks Table 24. Global Biobanking Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biobanking Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Biobanking Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Biobanking Sales Value Share by Application (2021-2026) Table 28. Global Biobanking Sales Value Share by Application (2027-2032) Table 29. Global Biobanking Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biobanking Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Biobanking Sales Value Share by Region (2021-2026) Table 32. Global Biobanking Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Biobanking Sales Value Share by Region (2027-2032) Table 34. Global Biobanking Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biobanking Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Biobanking Sales Value Market Share by Country (2021-2026) Table 37. Global Biobanking Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Biobanking Sales Value Market Share by Country (2027-2032) Table 39. Thermo Fisher Company Information Table 40. Thermo Fisher Business Overview Table 41. Thermo Fisher Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Thermo Fisher Biobanking Product Portfolio Table 43. Thermo Fisher Recent Development Table 44. Beckman Coulter Company Information Table 45. Beckman Coulter Business Overview Table 46. Beckman Coulter Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Beckman Coulter Biobanking Product Portfolio Table 48. Beckman Coulter Recent Development Table 49. Panasonic Company Information Table 50. Panasonic Business Overview Table 51. Panasonic Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Panasonic Biobanking Product Portfolio Table 53. Panasonic Recent Development Table 54. SOL Group Company Information Table 55. SOL Group Business Overview Table 56. SOL Group Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. SOL Group Biobanking Product Portfolio Table 58. SOL Group Recent Development Table 59. Promega Company Information Table 60. Promega Business Overview Table 61. Promega Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Promega Biobanking Product Portfolio Table 63. Promega Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Merck Biobanking Product Portfolio Table 68. Merck Recent Development Table 69. Greiner Bio One Company Information Table 70. Greiner Bio One Business Overview Table 71. Greiner Bio One Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Greiner Bio One Biobanking Product Portfolio Table 73. Greiner Bio One Recent Development Table 74. Chart Industries Company Information Table 75. Chart Industries Business Overview Table 76. Chart Industries Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Chart Industries Biobanking Product Portfolio Table 78. Chart Industries Recent Development Table 79. Brooks Life Science Company Information Table 80. Brooks Life Science Business Overview Table 81. Brooks Life Science Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Brooks Life Science Biobanking Product Portfolio Table 83. Brooks Life Science Recent Development Table 84. Tecan Group Company Information Table 85. Tecan Group Business Overview Table 86. Tecan Group Biobanking Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Tecan Group Biobanking Product Portfolio Table 88. Tecan Group Recent Development Table 89. QIAGEN Company Information Table 90. QIAGEN Business Overview Table 91. QIAGEN Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. QIAGEN Biobanking Product Portfolio Table 93. QIAGEN Recent Development Table 94. BD Company Information Table 95. BD Business Overview Table 96. BD Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. BD Biobanking Product Portfolio Table 98. BD Recent Development Table 99. Lifeline Scientific Company Information Table 100. Lifeline Scientific Business Overview Table 101. Lifeline Scientific Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Lifeline Scientific Biobanking Product Portfolio Table 103. Lifeline Scientific Recent Development Table 104. Hamilton Company Information Table 105. Hamilton Business Overview Table 106. Hamilton Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Hamilton Biobanking Product Portfolio Table 108. Hamilton Recent Development Table 109. So-Low Company Information Table 110. So-Low Business Overview Table 111. So-Low Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. So-Low Biobanking Product Portfolio Table 113. So-Low Recent Development Table 114. TTP Labtech Ltd Company Information Table 115. TTP Labtech Ltd Business Overview Table 116. TTP Labtech Ltd Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. TTP Labtech Ltd Biobanking Product Portfolio Table 118. TTP Labtech Ltd Recent Development Table 119. Biolife Solutions Company Information Table 120. Biolife Solutions Business Overview Table 121. Biolife Solutions Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. Biolife Solutions Biobanking Product Portfolio Table 123. Biolife Solutions Recent Development Table 124. DNA Genotek Company Information Table 125. DNA Genotek Business Overview Table 126. DNA Genotek Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. DNA Genotek Biobanking Product Portfolio Table 128. DNA Genotek Recent Development Table 129. Custom Biogenic Systems Company Information Table 130. Custom Biogenic Systems Business Overview Table 131. Custom Biogenic Systems Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 132. Custom Biogenic Systems Biobanking Product Portfolio Table 133. Custom Biogenic Systems Recent Development Table 134. LVL Technologies Company Information Table 135. LVL Technologies Business Overview Table 136. LVL Technologies Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 137. LVL Technologies Biobanking Product Portfolio Table 138. LVL Technologies Recent Development Table 139. BioRep Company Information Table 140. BioRep Business Overview Table 141. BioRep Biobanking Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 142. BioRep Biobanking Product Portfolio Table 143. BioRep Recent Development Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Biobanking Product Image Figure 2. Global Biobanking Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biobanking Market Size (2021-2032) & (US$ Million) Figure 4. Global Biobanking Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Equipment Image Figure 8. Consumable Image Figure 9. Global Biobanking Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biobanking Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biobanking Sales Value Share by Type (2021-2032) Figure 12. Virtual Biobanks Image Figure 13. Tissue Biobanks Image Figure 14. Population Biobanks Image Figure 15. Global Biobanking Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biobanking Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Biobanking Sales Value Share by Application (2021-2032) Figure 18. Global Biobanking Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Biobanking Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Biobanking Sales Value (2021-2032) & (US$ Million) Figure 21. North America Biobanking Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Biobanking Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Biobanking Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Biobanking Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Biobanking Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Biobanking Sales Value (2021-2032) & (US$ Million) Figure 27. South America Biobanking Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Biobanking Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Biobanking Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Biobanking Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Biobanking Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Biobanking Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Consumable
Applications
  • Virtual Biobanks
  • Tissue Biobanks
  • Population Biobanks
Companies covered
  • Thermo Fisher
  • Beckman Coulter
  • Panasonic
  • SOL Group
  • Promega
  • Merck
  • Greiner Bio One
  • Chart Industries
  • Brooks Life Science
  • Tecan Group
  • QIAGEN
  • BD
  • Lifeline Scientific
  • Hamilton
  • So-Low
  • TTP Labtech Ltd
  • Biolife Solutions
  • DNA Genotek
  • Custom Biogenic Systems
  • LVL Technologies
  • BioRep

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biobanking Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biobanking Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biobanking Market Dynamics
  1. 2.1 Biobanking Industry Trends
  2. 2.2 Biobanking Industry Drivers
  3. 2.3 Biobanking Industry Opportunities and Challenges
  4. 2.4 Biobanking Industry Restraints
3 Biobanking Market by Company
  1. 3.1 Global Biobanking Company Revenue Ranking in 2025
  2. 3.2 Global Biobanking Revenue by Company (2021-2026)
  3. 3.3 Global Biobanking Company Ranking (2024-2026)
  4. 3.4 Global Biobanking Company Manufacturing Base and Headquarters
  5. 3.5 Global Biobanking Company Product Type and Application
  6. 3.6 Global Biobanking Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biobanking Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biobanking Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biobanking Market by Type
  1. 4.1 Biobanking Type Introduction
  2. 4.1.1 Equipment
  3. 4.1.2 Consumable
  4. 4.2 Global Biobanking Sales Value by Type
  5. 4.2.1 Global Biobanking Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biobanking Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biobanking Sales Value Share by Type (2021-2032)
5 Biobanking Market by Application
  1. 5.1 Biobanking Application Introduction
  2. 5.1.1 Virtual Biobanks
  3. 5.1.2 Tissue Biobanks
  4. 5.1.3 Population Biobanks
  5. 5.2 Global Biobanking Sales Value by Application
  6. 5.2.1 Global Biobanking Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biobanking Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biobanking Sales Value Share by Application (2021-2032)
6 Biobanking Regional Value Analysis
  1. 6.1 Global Biobanking Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biobanking Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biobanking Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biobanking Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biobanking Sales Value (2021-2032)
  7. 6.3.2 North America Biobanking Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biobanking Sales Value (2021-2032)
  10. 6.4.2 Europe Biobanking Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biobanking Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biobanking Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biobanking Sales Value (2021-2032)
  16. 6.6.2 South America Biobanking Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biobanking Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biobanking Sales Value Share by Country, 2025 VS 2032
7 Biobanking Country-level Value Analysis
  1. 7.1 Global Biobanking Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biobanking Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biobanking Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biobanking Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biobanking Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biobanking Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biobanking Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biobanking Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biobanking Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biobanking Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biobanking Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biobanking Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biobanking Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biobanking Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biobanking Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biobanking Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biobanking Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biobanking Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biobanking Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biobanking Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biobanking Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biobanking Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biobanking Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biobanking Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biobanking Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biobanking Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biobanking Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biobanking Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biobanking Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biobanking Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biobanking Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biobanking Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biobanking Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biobanking Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biobanking Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biobanking Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biobanking Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biobanking Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biobanking Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biobanking Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biobanking Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biobanking Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biobanking Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biobanking Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biobanking Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biobanking Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biobanking Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biobanking Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biobanking Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biobanking Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biobanking Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biobanking Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biobanking Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biobanking Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biobanking Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biobanking Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biobanking Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biobanking Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biobanking Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biobanking Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biobanking Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biobanking Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biobanking Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biobanking Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biobanking Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biobanking Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biobanking Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biobanking Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biobanking Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biobanking Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biobanking Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biobanking Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biobanking Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biobanking Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biobanking Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biobanking Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biobanking Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biobanking Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biobanking Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biobanking Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biobanking Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biobanking Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biobanking Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biobanking Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biobanking Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biobanking Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biobanking Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biobanking Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher
  2. 8.1.1 Thermo Fisher Company Information
  3. 8.1.2 Thermo Fisher Business Overview
  4. 8.1.3 Thermo Fisher Biobanking Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Biobanking Product Portfolio
  6. 8.1.5 Thermo Fisher Recent Developments
  7. 8.2 Beckman Coulter
  8. 8.2.1 Beckman Coulter Company Information
  9. 8.2.2 Beckman Coulter Business Overview
  10. 8.2.3 Beckman Coulter Biobanking Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beckman Coulter Biobanking Product Portfolio
  12. 8.2.5 Beckman Coulter Recent Developments
  13. 8.3 Panasonic
  14. 8.3.1 Panasonic Company Information
  15. 8.3.2 Panasonic Business Overview
  16. 8.3.3 Panasonic Biobanking Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Panasonic Biobanking Product Portfolio
  18. 8.3.5 Panasonic Recent Developments
  19. 8.4 SOL Group
  20. 8.4.1 SOL Group Company Information
  21. 8.4.2 SOL Group Business Overview
  22. 8.4.3 SOL Group Biobanking Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SOL Group Biobanking Product Portfolio
  24. 8.4.5 SOL Group Recent Developments
  25. 8.5 Promega
  26. 8.5.1 Promega Company Information
  27. 8.5.2 Promega Business Overview
  28. 8.5.3 Promega Biobanking Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Promega Biobanking Product Portfolio
  30. 8.5.5 Promega Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Biobanking Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Biobanking Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Greiner Bio One
  38. 8.7.1 Greiner Bio One Company Information
  39. 8.7.2 Greiner Bio One Business Overview
  40. 8.7.3 Greiner Bio One Biobanking Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Greiner Bio One Biobanking Product Portfolio
  42. 8.7.5 Greiner Bio One Recent Developments
  43. 8.8 Chart Industries
  44. 8.8.1 Chart Industries Company Information
  45. 8.8.2 Chart Industries Business Overview
  46. 8.8.3 Chart Industries Biobanking Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chart Industries Biobanking Product Portfolio
  48. 8.8.5 Chart Industries Recent Developments
  49. 8.9 Brooks Life Science
  50. 8.9.1 Brooks Life Science Company Information
  51. 8.9.2 Brooks Life Science Business Overview
  52. 8.9.3 Brooks Life Science Biobanking Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Brooks Life Science Biobanking Product Portfolio
  54. 8.9.5 Brooks Life Science Recent Developments
  55. 8.10 Tecan Group
  56. 8.10.1 Tecan Group Company Information
  57. 8.10.2 Tecan Group Business Overview
  58. 8.10.3 Tecan Group Biobanking Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tecan Group Biobanking Product Portfolio
  60. 8.10.5 Tecan Group Recent Developments
  61. 8.11 QIAGEN
  62. 8.11.1 QIAGEN Company Information
  63. 8.11.2 QIAGEN Business Overview
  64. 8.11.3 QIAGEN Biobanking Revenue and Gross Margin (2021-2026)
  65. 8.11.4 QIAGEN Biobanking Product Portfolio
  66. 8.11.5 QIAGEN Recent Developments
  67. 8.12 BD
  68. 8.12.1 BD Company Information
  69. 8.12.2 BD Business Overview
  70. 8.12.3 BD Biobanking Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BD Biobanking Product Portfolio
  72. 8.12.5 BD Recent Developments
  73. 8.13 Lifeline Scientific
  74. 8.13.1 Lifeline Scientific Company Information
  75. 8.13.2 Lifeline Scientific Business Overview
  76. 8.13.3 Lifeline Scientific Biobanking Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Lifeline Scientific Biobanking Product Portfolio
  78. 8.13.5 Lifeline Scientific Recent Developments
  79. 8.14 Hamilton
  80. 8.14.1 Hamilton Company Information
  81. 8.14.2 Hamilton Business Overview
  82. 8.14.3 Hamilton Biobanking Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hamilton Biobanking Product Portfolio
  84. 8.14.5 Hamilton Recent Developments
  85. 8.15 So-Low
  86. 8.15.1 So-Low Company Information
  87. 8.15.2 So-Low Business Overview
  88. 8.15.3 So-Low Biobanking Revenue and Gross Margin (2021-2026)
  89. 8.15.4 So-Low Biobanking Product Portfolio
  90. 8.15.5 So-Low Recent Developments
  91. 8.16 TTP Labtech Ltd
  92. 8.16.1 TTP Labtech Ltd Company Information
  93. 8.16.2 TTP Labtech Ltd Business Overview
  94. 8.16.3 TTP Labtech Ltd Biobanking Revenue and Gross Margin (2021-2026)
  95. 8.16.4 TTP Labtech Ltd Biobanking Product Portfolio
  96. 8.16.5 TTP Labtech Ltd Recent Developments
  97. 8.17 Biolife Solutions
  98. 8.17.1 Biolife Solutions Company Information
  99. 8.17.2 Biolife Solutions Business Overview
  100. 8.17.3 Biolife Solutions Biobanking Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biolife Solutions Biobanking Product Portfolio
  102. 8.17.5 Biolife Solutions Recent Developments
  103. 8.18 DNA Genotek
  104. 8.18.1 DNA Genotek Company Information
  105. 8.18.2 DNA Genotek Business Overview
  106. 8.18.3 DNA Genotek Biobanking Revenue and Gross Margin (2021-2026)
  107. 8.18.4 DNA Genotek Biobanking Product Portfolio
  108. 8.18.5 DNA Genotek Recent Developments
  109. 8.19 Custom Biogenic Systems
  110. 8.19.1 Custom Biogenic Systems Company Information
  111. 8.19.2 Custom Biogenic Systems Business Overview
  112. 8.19.3 Custom Biogenic Systems Biobanking Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Custom Biogenic Systems Biobanking Product Portfolio
  114. 8.19.5 Custom Biogenic Systems Recent Developments
  115. 8.20 LVL Technologies
  116. 8.20.1 LVL Technologies Company Information
  117. 8.20.2 LVL Technologies Business Overview
  118. 8.20.3 LVL Technologies Biobanking Revenue and Gross Margin (2021-2026)
  119. 8.20.4 LVL Technologies Biobanking Product Portfolio
  120. 8.20.5 LVL Technologies Recent Developments
  121. 8.21 BioRep
  122. 8.21.1 BioRep Company Information
  123. 8.21.2 BioRep Business Overview
  124. 8.21.3 BioRep Biobanking Revenue and Gross Margin (2021-2026)
  125. 8.21.4 BioRep Biobanking Product Portfolio
  126. 8.21.5 BioRep Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst